Table 1.
GEO ID ref | Sample ID | Genotype | Sex | Treatment | Cells (× 10^6) | RIN score |
---|---|---|---|---|---|---|
GSM1376787 | Ab_EP2_1 | Cd11b-Cre; EP2 f/f | Female | Aβ | 2.40 | 9.8 |
GSM1376788 | Ab_EP2_2 | Cd11b-Cre; EP2 f/f | Female | Aβ | 2.40 | 9.9 |
GSM1376789 | Ab_EP2_3 | Cd11b-Cre; EP2 f/f | Female | Aβ | 2.00 | 8.7 |
GSM1376790 | Ab_WT_1 | CD11b-Cre; +/+ | Female | Aβ | 2.30 | 9.7 |
GSM1376791 | Ab_WT_2 | CD11b-Cre; +/+ | Female | Aβ | 1.65 | 9.4 |
GSM1376792 | Ab_WT_3 | CD11b-Cre; +/+ | Female | Aβ | 2.30 | 7.0 |
GSM1376793 | Ab_WT_4 | CD11b-Cre; +/+ | Female | Aβ | 1.75 | 7.7 |
GSM1376794 | Ab_WT_5 | CD11b-Cre; +/+ | Female | Aβ | 1.65 | 8.5 |
GSM1376795 | Ab_WT_6 | CD11b-Cre; +/+ | Female | Aβ | 0.95 | 9.6 |
GSM1376796 | Ab_WT_7 | CD11b-Cre; +/+ | Female | Aβ | 2.75 | 9.0 |
GSM1376797 | Veh_EP2_1 | Cd11b-Cre; EP2 f/f | Male | Veh | 1.50 | 9.4 |
GSM1376798 | Veh_EP2_2 | Cd11b-Cre; EP2 f/f | Female | Veh | 1.90 | 9.1 |
GSM1376799 | Veh_EP2_3 | Cd11b-Cre; EP2 f/f | Female | Veh | 1.65 | 9.9 |
GSM1376800 | Veh_WT_1 | CD11b-Cre; +/+ | Male | Veh | 1.12 | 9.8 |
GSM1376801 | Veh_WT_2 | CD11b-Cre; +/+ | Female | Veh | 1.25 | 9.6 |
GSM1376802 | Veh_WT_3 | CD11b-Cre; +/+ | Female | Veh | 1.50 | 8.6 |
GSM1376803 | Veh_WT_4 | CD11b-Cre; +/+ | Female | Veh | 1.70 | 10.0 |